Natural compounds as epigenetic modulators in gynaecological cancers: From chemoresistance to precision oncology
CONCLUSIONS: Natural compounds are mechanistically plausible but clinically under-validated adjunctive epigenetic modulators. Future development requires standardised formulations, improved delivery s